Byd Electronic Obtains Production License for E-Cigarettes in China

Aug.05.2022
BYD's subsidiary has obtained an e-cigarette manufacturing license, indicating its legal participation in the industry and potential competition.

In the past two years, with the successive release of new policies on electronic cigarette regulation, enterprises engaged in the production and operation of electronic cigarette products, vaporizers, and nicotine used in electronic cigarettes are required to obtain a production license, leading to some domestic electronic cigarette companies turning into the mainstream, and the electronic cigarette industry is moving towards a healthy and orderly development. Recently, BYD announced that it has obtained a production license, which means that BYD Electronics has officially participated in competition in the field of electronic cigarette OEMs with a legal identity.


BYD Electronics receives production license.


On August 4th, BYD Electronic announced on their official public account that their wholly-owned subsidiary, BYD Precision Manufacturing Co., Ltd., has been awarded a production license (for electronic cigarette processing enterprises) by the National Tobacco Monopoly Bureau. This means that BYD Electronic can now legally compete in the field of electronic cigarette processing.


BYD Electronic has announced that the company has completed the patent layout and automated production line for its full range of electronic atomization products. The company has integrated its own capabilities in new materials research and development, precision molds, product design and development, as well as intelligent manufacturing, with the goal of becoming a leader and practitioner in the field of health and harm reduction.


For A-share investors, BYD is best known for its new energy vehicles, to the extent that many people consider it to be just an auto company.


It is understood that BYD Electronic spun off from BYD and mainly engages in contract manufacturing of intelligent phones, masks, and e-cigarettes. As early as 2018, BYD Electronic has been laying out the e-cigarette business, and officially launched its ceramic atomization core (ceramic core) technology brand "BEEMCORE" in 2021.


It is worth mentioning that, on the morning of August 4th, BYD Electronic announced that it had been awarded a license to produce tobacco monopolies, and its stock price rose more than 12% at one point during the day, indicating the capital market's expectation for its electronic cigarette business.


Simaole's dominant market position may be challenged.


Aside from BYD Electronics, on the same day, SMIC announced on its official WeChat account, "SMIC Technology," that three fully-owned subsidiaries under the SMIC Group, Shenzhen McWalters Technology Co., Ltd., Shenzhen McBrother Technology Co., Ltd., and Shenzhen Weiplus Technology Co., Ltd., have been awarded the Tobacco Monopoly Bureau's production permits for tobacco monopoly enterprises. The issuance of these permits further strengthens SMIC's confidence in its future development, and the overall production and operation of the group will proceed according to the planned schedule.


It is undeniable that Smoore is currently the leading electronic cigarette company in China and even globally, and many institutions have high expectations for its development.


It is reported that in 2021, Smoore's global market share continued to expand to 22.8%, surpassing the total of the second to fifth places, and maintaining its position as the world's largest electronic atomization device manufacturer. However, Smoore's stock price has recently dropped significantly as investors believe that BYD and Luxshare Precision's entry into the industry will divide Smoore's market share and reduce their profitability.


However, industry insiders estimate that BYD's outsourcing capacity will not be too high, mainly because they are new to the industry and approved production capacity is mainly based on past business data. Some insiders have disclosed that the approved quantity for the pod is very low.


According to the "Regulations on the Management of Electronic Cigarettes" and related Q&A issued by the China National Tobacco Authority on March 11, 2022, anyone engaged in the production, wholesale, or retail of electronic cigarettes in China must obtain the relevant tobacco monopoly license. The regulations also specify that there will be a transition period from May 1, 2022 to September 30, 2022.


Starting from June, the government began conducting qualification and production capacity audits, which will continue until early October. This means that the production licenses and production capacity status of e-cigarette companies will be intensively disclosed in August and September. It is understood that both brand owners and factories are required to disclose their approved production capacity status.


Currently, it is a critical moment for license issuance. It is understood that regulatory agencies have established numerous teams to visit companies and conduct different types of inspections based on the industry. For example, for aerosol companies, the focus is on the completeness of licenses, compliance with site regulations, scientific manufacturing processes, quality control requirements, employee training and vocational education, as well as annual production capacity and sales history.


BYD Electronic stated that it will firmly support the national policies related to electronic cigarettes, operate its production in compliance with laws and regulations, and make positive contributions to the healthy and orderly development of the industry.


Simoer stated that in the future, they will continue to adhere to regulatory requirements and promote standardized, orderly development. They will also firmly support related national policies and operate in compliance with the law. Simultaneously, they will use scientific and technological innovation as the driving force for enterprise development, actively promote the long-term, healthy development of the industry, serve global customers and users, and fulfill their corporate responsibilities to contribute positively to society.


This article contains excerpts or reproductions of third-party information and its copyright belongs to the original media and author. If there is any infringement, please contact us for deletion. Any unit or individual who needs to reprint, please contact the author and do not reprint directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
According to Law360 on August 31, 2026, a federal judge in North Carolina ruled that a patent sublicense between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to continue paying royalties to Altria Client Services LLC over Vuse Alto. A jury had previously found that Vuse Alto infringed three Altria patents and awarded approximately $95.2 million in past damages, after which Reynolds was ordered to pay an ongoing royalty equal to 5.25% of positive net sales. The new ruling finds that a valid sublicense can eliminate future infringement, potentially ending what Altria described as hundreds of millions of dollars in future royalties.
Sep.01
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26